An open trial of reboxetine in obese patients with binge eating disorder.

Eating and weight disorders : EWD

Volumn 10, Issue 4, 2005, Pages e93-e96

  Silveira, R O ^a   Zanatto, V ^a   Appolinario J C ^a   Kapczinski, F ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; MORPHOLINE DERIVATIVE; REBOXETINE;

ADULT; ARTICLE; BULIMIA; CLINICAL TRIAL; FEMALE; HUMAN; OBESITY; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

ADRENERGIC UPTAKE INHIBITORS; ADULT; BULIMIA NERVOSA; FEMALE; HUMANS; MORPHOLINES; OBESITY; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 33745627539     PISSN: None     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/bf03327498     Document Type: Article

References (0)